Number of participants n (%) | Time in minutes median/mean (SDa) | Wilcoxon testb | |
---|---|---|---|
All participants | 2000 (100) | 4.00/4.48 (2.57) | |
Gender | |||
Women | 1124 (56.2) | 3.00/3.95 (2.00) | 10.99*** |
Men or other | 876 (43.8) | 4.00/5.17 (2.94) | |
Age | |||
Younger participants (18–25) | 225 (11.3) | 3.00/3.00 (1.08) | 11.20*** |
Participants > 25 | 1775 (88.7) | 4.00/4.67 (2.67) | |
Older participants (> 65) | 160 (8.0) | 5.00/6.14 (3.30) | − 9.03*** |
Participants < 65 | 1840 (92.0) | 4.00/4.34 (2.44) | |
Race | |||
Black/African American | 1112 (55.6) | 4.00/4.73 (2.58) | − 6.48*** |
Non-Black/African American | 888 (44.4) | 3.00/4.17 (2.52) | |
Ethnicity | |||
Hispanic | 233 (11.7) | 4.00/5.03 (3.00) | − 3.52*** |
Non-Hispanic | 1767 (88.3) | 4.00/4.41 (2.50) | |
Education level | |||
Less than high school (HS) | 383 (19.2) | 5.00/6.00 (3.26) | − 12.28*** |
HS or higher | 1617 (80.8) | 4.00/4.12 (2.23) | |
Alcohol use | |||
Screened positivec | 858 (42.9) | 4.00/4.61 (2.68) | − 1.87 |
Screened negative | 1142 (57.1) | 4.00/4.38 (2.48) | |
Illegal drug use | |||
Screened positivec | 492 (24.6) | 4.00/4.93 (2.52) | − 5.91*** |
Screened negative | 1508 (75.4) | 4.00/4.34 (2.57) | |
Prescription drug use | |||
Screened positivec | 245 (12.3) | 5.00/5.31 (2.72) | − 6.33*** |
Screened negative | 1755 (87.7) | 4.00/4.37 (2.53) | |
Order of administration | |||
myTAPS first | 1002 (50.1) | 4.00/4.85 (2.84) | 6.59*** |
Interviewer-administered first | 998 (49.9) | 4.00/4.11 (2.21) |